Christopher J. Kane
Impact in
- Pulmonary and Respiratory Medicine top 0.05%
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Renal cell carcinoma treatment
- Kidney Stones and Urolithiasis Treatments
- Urology top 0.2%
- Urinary Bladder and Prostate Research
Papers in
-
- Prostate Cancer Diagnosis and Treatment 218
- Prostate Cancer Treatment and Research 67
- Renal cell carcinoma treatment 25
- Kidney Stones and Urolithiasis Treatments 11
- Urology 17
- Urinary Bladder and Prostate Research 11
- Co-authors
- Christopher L. Amling (175 shared papers)Stephen J. Freedland (168 shared papers)William J. Aronson (168 shared papers)Martha K. Terris (168 shared papers)Joseph C. Presti (82 shared papers)Peter R. Carroll (39 shared papers)Matthew R. Cooperberg (96 shared papers)O. Fred Miller (3 shared papers)
- Journals
- The Journal of Urology (102 papers)Urology (46 papers)British Journal of Urology (32 papers)Cancer (32 papers)Prostate Cancer and Prostatic Diseases (25 papers)
- Partner nations
- United StatesCanadaJapan
In The Last Decade
Christopher J. Kane
397 papers receiving 20.0k citations
Christopher J. Kane's Hit Papers
Peers
Comparison fields: 5 of 163
- Pulmonary and Respiratory Medicine 12.8k
- Urology 1.1k
- Cancer Research 2.4k
- Oncology 2.5k
- Rheumatology 861
Countries citing papers authored by Christopher J. Kane
This map shows the geographic impact of Christopher J. Kane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Kane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Kane more than expected).
Fields of papers citing papers by Christopher J. Kane
This network shows the impact of papers produced by Christopher J. Kane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Kane. The network helps show where Christopher J. Kane may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher J. Kane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 416 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Molecular Taxonomy of Primary Prostate Cancer Hit paper breakdown → | 2015 | 2435 |
| 2 | Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology Hit paper breakdown → | 2019 | 1263 |
| 3 | Prostate Cancer, Version 1.2016 Hit paper breakdown → | 2016 | 568 |
| 4 | Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy Hit paper breakdown → | 2015 | 495 |
| 5 | Renal cell cancer stage migration Hit paper breakdown → | 2008 | 492 |
| 6 | Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial Hit paper breakdown → | 2016 | 488 |
| 7 | 1999 | 342 | |
| 8 | 2003 | 335 | |
| 9 | 2008 | 327 | |
| 10 | Association of Black Race With Prostate Cancer–Specific and Other-Cause Mortality Hit paper breakdown → | 2019 | 320 |
| 11 | Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management Hit paper breakdown → | 2022 | 311 |
| 12 | 2006 | 309 | |
| 13 | 2014 | 284 | |
| 14 | 2007 | 280 | |
| 15 | 2003 | 217 | |
| 16 | 2000 | 177 | |
| 17 | 2014 | 176 | |
| 18 | 2017 | 170 | |
| 19 | 1998 | 168 | |
| 20 | Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up Hit paper breakdown → | 2022 | 163 |
About Christopher J. Kane
Christopher J. Kane is a scholar working on Pulmonary and Respiratory Medicine, Urology, Surgery, Rheumatology and Oncology, having authored 416 papers that have together received 20.5k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (218 papers), Prostate Cancer Treatment and Research (67 papers), Renal cell carcinoma treatment (25 papers), Bladder and Urothelial Cancer Treatments (16 papers), Urologic and reproductive health conditions (12 papers), Kidney Stones and Urolithiasis Treatments (11 papers), Urinary Bladder and Prostate Research (11 papers) and Epigenetics and DNA Methylation (10 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (12.8k citations), Urology (1.1k citations), Cancer Research (2.4k citations), Oncology (2.5k citations) and Rheumatology (861 citations). Christopher J. Kane has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include Christopher L. Amling, Stephen J. Freedland, William J. Aronson, Martha K. Terris, Joseph C. Presti, Peter R. Carroll, Matthew R. Cooperberg, O. Fred Miller, Katherine Mallin and Prodromos G. Borboroglu. Their work appears in journals such as The Journal of Urology, Urology, British Journal of Urology, Cancer and Prostate Cancer and Prostatic Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.